HOXA7 stimulates human hepatocellular carcinoma proliferation through cyclin E1/CDK2

Area of Science:

• Molecular Biology
• Oncology
• Genetics

Background:

• HOX genes are crucial transcription factors regulating cell development.
• Emerging evidence links HOX genes to hepatocellular carcinoma (HCC) progression.
• The specific roles and mechanisms of HOX genes in HCC remain underexplored.

Purpose of the Study:

• To elucidate the functional role of HOXA7 in regulating HCC cell proliferation.
• To investigate the underlying molecular mechanisms of HOXA7 action in HCC.
• To assess HOXA7 as a potential therapeutic target for HCC.

Main Methods:

• Utilized small interfering RNA (siRNA) for HOXA7 knockdown in HepG2 and QGY-7703 HCC cell lines.
• Employed forced gene expression to overexpress HOXA7 in QSG-7701 cells.
• Analyzed cell proliferation rates and protein levels of cyclins (cyclin E1) and cyclin-dependent kinases (CDK2, CDK4).
• Evaluated HOXA7's effects both in vitro and in vivo.

Main Results:

• Downregulation of HOXA7 significantly inhibited proliferation in HepG2 and QGY-7703 cells.
• HOXA7 knockdown led to reduced protein levels of cyclin E1 and CDK2, but not cyclin D1 or CDK4.
• Overexpression of HOXA7 in QSG-7701 cells stimulated proliferation and increased cyclin E1/CDK2 levels.
• HOXA7's proliferative effects were confirmed to be mediated by the cyclin E1/CDK2 pathway.

Conclusions:

• HOXA7 plays a significant role in promoting HCC cell proliferation.
• The mechanism involves the regulation of the cyclin E1/CDK2 pathway.
• HOXA7 represents a promising molecular target for novel HCC diagnostic and therapeutic strategies.